Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains
  1. Home
  3. Research Domains

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Molecular Basis Of The Vhl Hereditary Cancer Syndrome.
  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Molecular Basis Of The Vhl Hereditary Cancer Syndrome.

    • Related Experiment Videos

    Molecular basis of the VHL hereditary cancer syndrome.

    William G Kaelin1

    • 1Howard Hughes Medical Institute, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. william_kaelin@dfci.harvard.edu

    Nature Reviews. Cancer
    |September 5, 2002

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    The von Hippel-Lindau gene (VHL) is key to how cells sense oxygen. Research into VHL is uncovering new ways to treat cancers and other diseases like heart attack and stroke.

    Related Experiment Videos

    Area of Science:

    • Genetics
    • Molecular Biology
    • Cellular Biology

    Background:

    • The von Hippel-Lindau hereditary cancer syndrome, known for over a century, exhibits unique clinical features.
    • These features suggested a role for the von Hippel-Lindau gene (VHL) in cellular oxygen sensing.
    • Understanding VHL's function is crucial for deciphering cellular responses to oxygen fluctuations.

    Purpose of the Study:

    • To elucidate the role of the von Hippel-Lindau gene (VHL) in the cellular oxygen-sensing pathway.
    • To explore the implications of VHL function in intracellular signaling.
    • To lay the groundwork for novel therapeutic strategies targeting VHL-related pathways.

    Main Methods:

    • Genetic analysis of the von Hippel-Lindau gene (VHL).
    • Investigation of cellular responses to varying oxygen levels.
    • Biochemical studies on prolyl hydroxylation in intracellular signaling.

    Main Results:

    • Studies on the VHL gene have significantly advanced the understanding of cellular oxygen sensing mechanisms.
    • A previously unrecognized role for prolyl hydroxylation in intracellular signaling has been identified.
    • These findings link VHL function to fundamental cellular processes.

    Conclusions:

    • The von Hippel-Lindau gene (VHL) plays a critical role in cellular oxygen detection.
    • Prolyl hydroxylation is an important signaling mechanism within cells.
    • This research provides a foundation for treating diseases such as cancer, myocardial infarction, and stroke.